Table 1 Baseline characteristics of the study population, overall and by AID system.
Total (n = 142) | Tandem Control IQ (n = 92) | MiniMed 780G (n = 50) | |
|---|---|---|---|
Age (years) | 41.9 [14.2] | 40.4 [14.0] | 44.7 [14.1] |
Female sex, n (%) | 58 (40.8) | 41 (44.6) | 17 (34.0) |
Diabetes duration (years) | 23.3 [12.3] | 21.5 [11.8] | 26.6 [12.7] |
Time in range (70–180 mg/dL; 3.9–10.0 mmol/L), (%) | 56.4 [17.3] | 53.1 [17.6] | 62.6 [15.2] |
HbA1c (%) | 7.3 [1.1] | 7.4 [1.2] | 7.2 [0.9] |
HbA1c (mmol/mol) | 56.6 [11.7] | 57.2 [12.7] | 55.7 [9.8] |
Smoking status, n (%) | |||
Current | 6 (4.5) | 2 (2.3) | 4 (8.3) |
Former | 24 (17.9) | 17 (19.8) | 7 (14.6) |
Never | 104 (77.6) | 67 (77.9) | 37 (77.1) |
BMI (kg/m2) | 27.5 [4.5] | 27.3 [4.8] | 27.8 [4.0] |
Macroalbuminuria, n (%) | 4 (3.0) | 1 (1.2) | 3 (6.4) |
Microalbuminuria, n (%) | 5 (3.8) | 4 (4.7) | 1 (2.1) |
eGFR (mL/min/1.73 m²) | 106 [96–117] | 111 [98–119] | 102 [89–111] |
Retinopathy, n (%) | |||
Mild | 49 (36.3) | 32 (37.2) | 17 (34.7) |
Moderate | 19 (14.1) | 11 (12.8) | 8 (16.3) |
Severe | 22 (16.3) | 9 (10.5) | 13 (26.5) |
Previous MI, CABG, or PCI, n (%) | 4 (3.0) | 1 (1.2) | 3 (6.3) |
Previous amputation, n (%) | 2 (1.5) | 1 (1.2) | 1 (2.1) |
Treatment prior to AID, n (%) | |||
MDI | 38 (26.8) | 31 (33.7) | 7 (14.0) |
CSII | 104 (73.2) | 61 (66.3) | 43 (86.0) |
CGM system prior to AID, n (%) | |||
Dexcom G6 | 90 (65.2) | 89 (98.9) | 1 (2.1) |
Guardian 3 | 19 (13.8) | 0 (0.0) | 19 (39.6) |
Guardian 4 | 29 (21.0) | 1 (1.1) | 28 (58.3) |